Review: taking Tamsulosin hydrochloride and Tolterodine tartrate together


Summary

Drug interactions are reported among people who take Tamsulosin hydrochloride and Tolterodine tartrate together. This review analyzes the effectiveness and drug interactions between Tamsulosin hydrochloride and Tolterodine tartrate. It is created by eHealthMe based on reports of 612 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Tamsulosin Hydrochloride

Tamsulosin hydrochloride has active ingredients of tamsulosin hydrochloride. It is often used in enlarged prostate. (latest outcomes from Tamsulosin hydrochloride 3,956 users)

Tolterodine Tartrate

Tolterodine tartrate has active ingredients of tolterodine tartrate. It is often used in hypertonic bladder. (latest outcomes from Tolterodine tartrate 1,989 users)

On Sep, 08, 2016

612 people who take Tamsulosin Hydrochloride, Tolterodine Tartrate are studied.


Number of reports submitted per year:

Tamsulosin hydrochloride and Tolterodine tartrate drug interactions.

Drug effectiveness over time:

Tamsulosin Hydrochloride:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 66.0% - (2 of 3 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Tolterodine Tartrate:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 33.0% - (1 of 3 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 33.0% - (1 of 3 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Tamsulosin Hydrochloride:
  • female: 0.0% - (0 of 0 people)
  • male: 41.0% - (5 of 12 people)
Tolterodine Tartrate:
  • female: 0.0% - (0 of 0 people)
  • male: 33.0% - (4 of 12 people)

Drug effectiveness by age:

Tamsulosin Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 33.0% - (1 of 3 people)
  • 60+: 57.0% - (4 of 7 people)
Tolterodine Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 100.0% - (2 of 2 people)
  • 60+: 25.0% - (2 of 8 people)

Most common drug interactions over time *:

< 1 month:
  • fall
  • oxygen saturation decreased
  • pyrexia
  • serum sickness
  • tachycardia
  • confusional state
  • constipation
  • disorientation
  • sinus congestion
  • abdominal pain
1 - 6 months:
  • confusional state
  • disorientation
  • fall
  • sinus congestion
  • cor pulmonale chronic
  • cough
  • drug ineffective
  • emphysema
  • fatigue
  • gastrooesophageal reflux disease
6 - 12 months:
  • cor pulmonale chronic
  • cough
  • diarrhea
  • fatigue
  • flatulence
  • gastrooesophageal reflux disease
  • hypertensive nephropathy
  • malaise
  • musculoskeletal disorder
  • osteoarthritis
1 - 2 years:
  • hip arthroplasty
  • hypertonic bladder
  • musculoskeletal chest pain
  • pneumonia
  • drug chemical incompatibility
  • drug effect decreased
  • drug effect increased
  • drug ineffective
  • gastrointestinal haemorrhage
  • glaucoma
2 - 5 years:
  • musculoskeletal chest pain
5 - 10 years:
  • acute pancreatitis
  • myocardial infarction
  • urinary retention
not specified:
  • fall
  • asthenia
  • pain
  • depression
  • weight decreased
  • anaemia
  • dyspnoea
  • drug ineffective
  • dizziness
  • fatigue

Most common drug interactions by gender *:

female:
  • fall
  • multiple sclerosis relapse
  • urinary tract infection
  • progressive multifocal leukoencephalopathy
  • bladder dysfunction
  • fatigue
  • arthralgia
  • asthenia
  • bone disorder
  • femur fracture
male:
  • fall
  • asthenia
  • depression
  • weight decreased
  • pain
  • anaemia
  • drug ineffective
  • dyspnoea
  • dizziness
  • fatigue

Most common drug interactions by age *:

0-1:
  • activities of daily living impaired
  • anhedonia
  • anxiety
  • balance disorder
  • bronchitis
  • extrapyramidal disorder
  • injury
  • muscle spasms
  • myoclonus
  • neuropathy peripheral
2-9:
  • hypertension
  • abdominal distension
  • abdominal pain
  • abnormal behaviour
  • acrochordon
  • amnesia
  • anaemia
  • animal bite
  • anogenital warts
  • arrhythmia
20-29:
  • back pain
  • body height decreased
  • cardio-respiratory arrest
  • cerebral infarction
  • cerebrovascular accident
  • chronic obstructive pulmonary disease
  • fall
  • hemiparesis
  • hypoaesthesia
  • influenza like illness
30-39:
  • alanine aminotransferase decreased
  • asthenia
  • bladder pain
  • bladder spasm
  • convulsion
  • urinary incontinence
  • abdominal pain lower
  • anxiety
  • blood chloride decreased
  • communication disorder
40-49:
  • depression
  • musculoskeletal pain
  • chest pain
  • constipation
  • fall
  • urinary tract infection
  • abdominal pain
  • arthralgia
  • back pain
  • cardiac disorder
50-59:
  • weight decreased
  • respiratory failure
  • infection
  • abscess jaw
  • acute myocardial infarction
  • bone density decreased
  • bone disorder
  • cardiac murmur
  • concomitant disease progression
  • dental caries
60+:
  • fall
  • fatigue
  • asthenia
  • pyrexia
  • dizziness
  • anaemia
  • confusional state
  • constipation
  • dyspnoea
  • pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tamsulosin hydrochloride and Tolterodine tartrate?

Can you answer these questions?

More questions for: Tamsulosin hydrochloride, Tolterodine tartrate

You may be interested in these reviews

More reviews for: Tamsulosin hydrochloride, Tolterodine tartrate

On eHealthMe, Tamsulosin hydrochloride (tamsulosin hydrochloride) is often used to treat enlarged prostate. Tolterodine tartrate (tolterodine tartrate) is often used to treat hypertonic bladder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.